Top Markets
Coin of the day
Histogen Inc. Histogen Inc.

Histogen Inc.

HSTO
Rang in Aktien #40868
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on... Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.
Aktienkurs
$0.02765
Zuletzt synchronisiert: 2024-12-23
Marktkapitalisierung
$69.04K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Histogen Inc. (HSTO)

Kategorie

Aktien-Split-Historie für Histogen Inc. (HSTO)
Die Aktie Histogen Inc. (Symbol: HSTO) durchlief insgesamt 2 Aktiensplits.
Der letzte Aktiensplit fand am Jun 03, 2022 statt.
Eine HSTO-Aktie, die vor dem May 27, 2020 gekauft wurde, entspricht heute 0.005 HSTO-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
2022-06-03 1:20 x0.05 x0.005
2020-05-27 1:10 x0.1 x0.1
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE